AstraZeneca
News Article
Amyloid transthyretin polyneuropathy is a rare and fatal disease that can affect up to 40,000 people worldwide, said AstraZeneca’s Mene Pangalos.
Subscribe to Amyloid transthyretin polyneuropathy